Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

GWH March 5, 2026

ESS Tech Inc. Q4 2025 Earnings Call - Project New Horizon confirms tier-one commercial pivot with Google and SRP

ESS spent 2025 threading the needle between survival and scale. Management has pivoted fully to the Energy Base long-duration iron flow product, pared costs, bolstered liquidity, and stitched together...

  • Project New Horizon is the call’s centerpiece: a 5 MW / 50 MWh Energy Base deployment at SRP’s Copper Crossing, with Google confirmed as an offtaker and multi-year testing partner; manufacturing starts in 2026, delivery targeted December 2027.
  • ESS won a $9.9 million contract via Concurrent Technologies Corporation and the US Air Force Research Laboratory for deployment at Clear Space Force Station in Alaska, marking a defense credential for iron flow technology.
  • Company has completed a strategic pivot to the Energy Base product, winding down legacy Energy Warehouse and Energy Center lines; management expects most revenue from new product to land in 2027–2028, not 2026.
  • +12 more takeaways
GROV March 5, 2026

Grove Collaborative Holdings Q4 2025 Earnings Call - Returned to Positive Adjusted EBITDA While Rebuilding Post-Platform Migration

Grove finished 2025 with a mixed scorecard. Revenue slid as the company worked through a disruptive e-commerce platform migration, but disciplined cost cuts and paused marketing produced a return to p...

  • Q4 revenue was $42.4 million, down 14.3% year-over-year; full year 2025 revenue was $173.7 million, down 14.6% YoY but within revised guidance.
  • Grove returned to positive adjusted EBITDA in Q4 2025: $1.6 million, a 3.7% margin, versus negative $1.6 million in the prior-year quarter; full year adjusted EBITDA was -$2.2 million.
  • Net loss in Q4 was $1.6 million (3.7% margin), materially improved from a $12.6 million net loss (25.5% margin) in the prior-year quarter; full year net loss was $11.7 million.
  • +12 more takeaways
SWBI March 5, 2026

Smith & Wesson Brands Incorporated Q3 Fiscal 2026 Earnings Call - Handgun share surge lifts ASPs, margins and cash flow

Smith & Wesson reported a muscular Q3 driven by handgun momentum. Net sales rose 17.1% to $135.7 million, adjusted EBITDA was $16.8 million, and adjusted EPS came in at $0.08. Handgun unit shipments i...

  • Net sales rose 17.1% year over year to $135.7 million in Q3 fiscal 2026, driven primarily by new handgun products.
  • Adjusted EBITDA was $16.8 million, up nearly 21% versus the prior year period.
  • Adjusted (non-GAAP) EPS was $0.08 in Q3, compared with $0.03 a year ago; GAAP EPS was $0.08 versus $0.05 prior year.
  • +16 more takeaways
FLL March 5, 2026

Full House Resorts Q4 2025 Earnings Call - American Place momentum, financing close and permanent build next

Full House reported a solid Q4 and full-year 2025, led by continued acceleration at its temporary American Place casino in Waukegan and tangible operational fixes in Colorado. Q4 revenue rose to $75.4...

  • Q4 2025 revenue was $75.4 million, up from $73.0 million in Q4 2024; apples-to-apples revenue growth was 5.6% after removing sold asset revenue.
  • Q4 adjusted EBITDA rose to $10.7 million versus $10.4 million in Q4 2024, and management says stripping prior-year one-offs implies roughly 23% growth.
  • American Place temporary casino: Q4 revenue $32 million, up 11%, and adjusted property EBITDA $8.7 million, up 29%. Full-year American Place revenue was $124 million and adjusted property EBITDA $34.3 million, up 13% and 17% respectively.
  • +12 more takeaways
COOK March 5, 2026

Traeger, Inc. Q4 2025 Earnings Call - Project Gravity reshapes business, trims revenue now for stronger margins later

Traeger closed fiscal 2025 with revenue of $560 million and Adjusted EBITDA of $70 million, beating guidance while navigating tariff-driven volatility. Management framed 2026 as a transition year, tra...

  • Full year 2025 revenue was $560 million, above the high end of guidance, and Adjusted EBITDA was $70 million, in the upper half of the guided range.
  • 2026 guidance is a marked step down: revenue $465 million-$485 million and Adjusted EBITDA $50 million-$60 million, with management calling 2026 a foundational, transition year.
  • Project Gravity has grown in scope, now expected to deliver $64 million-$70 million of total run-rate value, including an incremental $6 million-$12 million of SKU and pricing capture that mostly accrues in 2027-2028.
  • +16 more takeaways
OPRX March 5, 2026

OptimizeRx Q4 2025 Earnings Call - Profitability Levers Strong, But MFN Headwinds and Managed-Services Drop Cloud Early-2026 Revenue

OptimizeRx closed FY2025 with solid operating leverage, beating expectations in Q4 with $32.2 million in revenue and $12.0 million adjusted EBITDA, and full-year revenue of $109.4 million with adjuste...

  • Q4 2025 revenue $32.2 million, adjusted EBITDA $12.0 million; FY2025 revenue $109.4 million, adjusted EBITDA $24.3 million.
  • Q4 gross margin rose to 74.8%, driven by an unusually favorable mix of specialty messaging and channel partners; management expects mid-60% gross margins in 2026.
  • Company generated nearly $19 million in operating free cash flow for 2025, raising cash and short-term investments to $23.4 million versus $13.4 million a year earlier.
  • +11 more takeaways
OWLT March 5, 2026

Owlet Q4 2025 Earnings Call - Subscription Momentum: 110,000 Owlet360 Subscribers and Path to Recurring Revenue Growth

Owlet closed 2025 with a record year, driven by the launch and rapid scaling of its Owlet360 subscription and the Dream product suite. Full year revenue hit $105.7 million, up 35.4% year over year, an...

  • Owlet reported Q4 2025 revenue of $26.6 million, up 29.6% year over year, and full year 2025 revenue of $105.7 million, up 35.4% versus 2024.
  • Owlet360 subscription reached over 110,000 paying subscribers as of early March, marking the first full year of the service since its January 2025 launch.
  • Full year 2025 gross margin was a record 50.6% despite tariff headwinds, Q4 gross margin was 47.6% which included an estimated 510 basis point tariff impact.
  • +17 more takeaways
AEYE March 5, 2026

AudioEye Q4 2025 Earnings Call - Guides 30% Adjusted EBITDA Growth in 2026, Betting on AI Efficiency and ARR Acceleration

AudioEye closed 2025 with streaky momentum and cleaner economics. The company reported its 40th consecutive quarter of sequential revenue growth, record full-year revenue, and a 35% jump in adjusted E...

  • AudioEye reported its 40th consecutive quarter of sequential revenue growth and record full-year 2025 revenue.
  • Adjusted EBITDA for 2025 was a record $9.1 million, up approximately 35% year-over-year, with an adjusted EBITDA margin of 22%.
  • Management guides 2026 adjusted EBITDA to grow by at least 30%, implying at least $11.8 million for the year and a run rate target of $15 million by year-end driven by AI efficiencies.
  • +14 more takeaways
AVIR March 5, 2026

Atea Pharmaceuticals Fourth Quarter 2025 Earnings Call - Phase 3 HCV readouts set to define 2026 with cash runway through 2027

Atea says 2026 is a make-or-break year. The company expects top-line results from its global phase 3 HCV program this year, with C-BEYOND readout midyear and C-FORWARD by year-end, while maintaining r...

  • Company-wide focus for 2026 is delivery of phase 3 HCV top-line readouts: C-BEYOND midyear and C-FORWARD by year-end.
  • HCV regimen under study is bemnifosbuvir plus ruzasvir, evaluated head-to-head versus sofosbuvir/velpatasvir (Epclusa).
  • Atea states its global phase 3 program will enroll more than 1,760 patients across two trials, C-BEYOND (North America) and C-FORWARD (rest of world).
  • +13 more takeaways
AKA March 5, 2026

a.k.a. Brands Holding Corp. Q4 FY2025 Earnings Call - Guides FY2026 as an Inflection Year with Mid-Single Digit Sales Growth and Material EBITDA Expansion

a.k.a. Brands closed FY25 with modest top-line growth and a recalibrated foundation, and management is calling 2026 an inflection year. The company grew net sales 4.4% to $600 million, sharpened inven...

  • FY25 net sales grew 4.4% to $600.0 million, 5.0% on a constant currency basis.
  • Management calls FY26 an inflection year, guiding net sales of $625 million to $635 million, and adjusted EBITDA of $27 million to $29 million.
  • Tariffs were a material headwind in FY25, management estimates roughly 100 basis points of gross margin pressure from tariff-related sourcing costs.
  • +11 more takeaways